The impact of vaping aerosol exposure on innate pulmonary defense mechanisms in nonhuman primates
电子烟气溶胶暴露对非人灵长类动物先天肺防御机制的影响
基本信息
- 批准号:10428016
- 负责人:
- 金额:$ 20.05万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-04-01 至 2025-03-31
- 项目状态:未结题
- 来源:
- 关键词:2019-nCoVAcuteAdolescentAdolescent and Young AdultAdoptionAerosolsAffectAlveolarAlveolar MacrophagesAnatomyAnimal ModelAreaAutopsyBiological AssayBronchiolitisBronchoalveolar Lavage FluidCellsCenters for Disease Control and Prevention (U.S.)Centers of Research ExcellenceCessation of lifeChadClinicalDataDefense MechanismsDefensinsDevelopment PlansDevicesDiffuseDiseaseDisease OutbreaksDisease modelDyspneaEducational workshopEnsureEnvironmentEnzyme-Linked Immunosorbent AssayExposure toFlow CytometryFoundationsFunctional disorderFundingFunding AgencyFutureGoalsGrantHIVHospitalizationHumanImmuneImmunohistochemistryImmunologyIndividualInflammationInflammatoryInnate Immune ResponseInnate Immune SystemInvestigationLipidsLiquid substanceLower respiratory tract structureLungLung immune responseMacaca mulattaMentorsMentorshipMicroscopicModelingNational Heart, Lung, and Blood InstituteNational Institute of Allergy and Infectious DiseaseNational Institute of Drug AbuseOnset of illnessPathogenesisPathogenicityPathologicPatientsPhagocytesPhagocytosisPhenotypePhysiologyPlayPneumoniaPoliciesPositioning AttributePrimatesPrivatizationPublic HealthPulmonary InflammationPulmonary PathologyPulmonary function testsReportingResearchResearch PersonnelResourcesRespiratory DiseaseRodent ModelRoleSIVSalineSamplingStudy modelsSystemTerminal BronchioleTestingTetrahydrocannabinolTimeTissuesToll-like receptorsTrainingTreesTumor-infiltrating immune cellsUnited States National Institutes of HealthVitamin E AcetateWritingaerosolizedairway inflammationbasecareercareer developmentchemokinecomorbiditycytokineelectronic vapeimprovedinnate immune functioninnate immune mechanismsinterestliquid nicotinemacrophagenonhuman primatenovelpulmonary functionradiological imagingreceptor expressionresponseskillssuccesssurfactanttargeted treatmentvapingvaping associated lung injury
项目摘要
PROJECT SUMMARY
Vaping is a serious public health concern that was associated with outbreaks of hospitalizations and deaths in
2019. These outbreaks of electronic vaping associated lung injury (EVALI) coincided with increased use of
electronic vaping devices by adolescents and young adults. The rapid disease onset of EVALI and the role of
macrophages in its progression, support a role for the innate immune system in the pathogenesis of EVALI.
Despite its rising use little is currently known about the effect of vaping on pulmonary immunology and physiology
highlighting the need for animal models to better understand its effects. Small animal models have shown
pathologic changes following exposure to vaping aerosols; however, they do not recapitulate the pathologic
manifestations of EVALI reported in humans necessitating a more translatable animal model to investigate the
pathogenesis of EVALI. Nonhuman primates (NHPs) are ideally suited for studying respiratory diseases in
humans due to their similarity in both pulmonary anatomy and immunology which provide advantages over other
animal models. Here, we aim to utilize a NHP model to investigate the impact of vaping aerosol exposure on
innate pulmonary defense mechanisms. We will longitudinally assess pulmonary and innate immune function
(immune cell infiltrates, alveolar macrophage phagocytosis, and secretion of cytokines, chemokines, and
defense molecules) over a four-week period of daily vaping aerosol exposure. At the end of the study, correlation
with pathologic changes will occur through rigorous postmortem examination and sampling of the upper and
lower respiratory tract. The data generated from this study will inform on mechanisms by which vaping aerosols
effect innate pulmonary defenses, an important area of investigation in this time of highly infectious respiratory
diseases. Furthermore, this study will provide preliminary data for future investigations evaluating the contribution
of individual constituents within the vaping liquid (nicotine, tetrahydrocannabinol, and vitamin E acetate); and
vaping in the context of comorbid conditions (SARS-CoV-2 and HIV/SIV), areas of special interest supported by
several funding agencies (NIDA, NHLBI, NIAID). This proposed study and Mentored Career Development Plan
will be conducted at the Tulane National Primate Research Center under the guidance of Drs. Ronald Veazey
and Chad Roy. The TNPRC has been a national resource and center of excellence for biomedical research
using nonhuman primates for over 50 years. The TNPRC has a strong commitment to training and mentorship
and provides support (financial and effort-based) to create a rich and diverse training environment for early-stage
investigators. The TNPRC fully supports Dr. Blair in his career goal to develop into an independently funded
private investigator working with NHP models to study diseases of major public health importance. The dedicated
time and additional mentorship provided by this K01 will help Dr. Blair refine his grant writing and project
management skills to ensure the success of his future R01 proposals.
项目概要
电子烟是一个严重的公共卫生问题,与许多国家住院和死亡的爆发有关
2019 年。这些电子烟相关肺损伤 (EVALI) 的爆发与电子烟使用的增加同时发生。
青少年和年轻人使用电子烟设备。 EVALI 的快速发病及其作用
巨噬细胞在其进展过程中支持先天免疫系统在 EVALI 发病机制中的作用。
尽管电子烟的使用量不断增加,但目前人们对电子烟对肺部免疫学和生理学的影响知之甚少。
强调需要动物模型来更好地了解其影响。小动物模型显示
暴露于电子烟气溶胶后的病理变化;然而,它们并没有概括病理学
据报道,EVALI 在人类中的表现需要更可转化的动物模型来研究
EVALI 的发病机制。非人类灵长类动物 (NHP) 非常适合研究呼吸道疾病
人类由于其肺部解剖学和免疫学方面的相似性而比其他疾病具有优势
动物模型。在这里,我们的目标是利用 NHP 模型来研究电子烟气溶胶暴露对
先天性肺防御机制。我们将纵向评估肺和先天免疫功能
(免疫细胞浸润、肺泡巨噬细胞吞噬作用以及细胞因子、趋化因子和
防御分子)在为期四个星期的每日电子烟气溶胶暴露期间。研究结束时,相关性
通过严格的尸检和上部和上部取样,将发生病理变化
下呼吸道。这项研究产生的数据将揭示电子烟气溶胶的机制
影响先天性肺部防御,这是这个高度传染性呼吸道疾病时期的一个重要研究领域
疾病。此外,本研究将为未来评估贡献的调查提供初步数据
电子烟液体中的各个成分(尼古丁、四氢大麻酚和维生素 E 醋酸酯);和
在合并症(SARS-CoV-2 和 HIV/SIV)的背景下使用电子烟,这是由以下机构支持的特别感兴趣的领域
多个资助机构(NIDA、NHLBI、NIAID)。这项拟议的研究和指导职业发展计划
将在杜兰国家灵长类动物研究中心进行,博士的指导下。罗纳德·维泽
和查德·罗伊。 TNPRC 一直是生物医学研究的国家资源和卓越中心
使用非人类灵长类动物已有 50 多年的历史。 TNPRC 坚定致力于培训和指导
并提供支持(资金和精力),为早期阶段创造丰富多样的培训环境
调查人员。 TNPRC 全力支持 Blair 博士发展成为独立资助的
私人调查员使用 NHP 模型研究具有重大公共卫生重要性的疾病。专注的
K01 提供的时间和额外指导将帮助 Blair 博士完善他的资助写作和项目
管理技能,以确保他未来的 R01 提案取得成功。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Robert Blair其他文献
Robert Blair的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Robert Blair', 18)}}的其他基金
The impact of vaping aerosol exposure on innate pulmonary defense mechanisms in nonhuman primates
电子烟气溶胶暴露对非人灵长类动物先天肺防御机制的影响
- 批准号:
10594499 - 财政年份:2022
- 资助金额:
$ 20.05万 - 项目类别:
Automated Staining Platform for Immunohistochemistry and In Situ Hybridization
用于免疫组织化学和原位杂交的自动化染色平台
- 批准号:
10177257 - 财政年份:2021
- 资助金额:
$ 20.05万 - 项目类别:
相似国自然基金
剪接因子U2AF1突变在急性髓系白血病原发耐药中的机制研究
- 批准号:82370157
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
IKZF1-N159Y/S热点突变在急性白血病中的致病机制研究
- 批准号:82300168
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
NMNAT1上调B7-H3介导急性早幼粒细胞白血病免疫逃逸的作用和机制研究
- 批准号:82300169
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
支链氨基酸转氨酶1在核心结合因子急性髓细胞白血病中的异常激活与促进白血病发生的分子机制研究
- 批准号:82370178
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
SRSF3/LRP5/Wnt信号通路在急性淋巴细胞白血病中的作用及机制研究
- 批准号:82370128
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
CNS-mediated fever after Adolescent Intermittent Ethanol
青少年间歇性饮酒后中枢神经系统介导的发热
- 批准号:
10607154 - 财政年份:2023
- 资助金额:
$ 20.05万 - 项目类别:
The impact of vaping aerosol exposure on innate pulmonary defense mechanisms in nonhuman primates
电子烟气溶胶暴露对非人灵长类动物先天肺防御机制的影响
- 批准号:
10594499 - 财政年份:2022
- 资助金额:
$ 20.05万 - 项目类别:
Identifying biomarker signatures of prognostic value for Multisystem Inflammatory Syndrome in Children (MIS-C)
识别儿童多系统炎症综合征 (MIS-C) 预后价值的生物标志物特征
- 批准号:
10651536 - 财政年份:2022
- 资助金额:
$ 20.05万 - 项目类别:
Identifying biomarker signatures of prognostic value for Multisystem Inflammatory Syndrome in Children (MIS-C)
识别儿童多系统炎症综合征 (MIS-C) 预后价值的生物标志物特征
- 批准号:
10320491 - 财政年份:2021
- 资助金额:
$ 20.05万 - 项目类别:
COVID-19 Network of Networks Expanding Clinical and Translational approaches to Predict Severe Illness in Children (CONNECT to Predict SIck Children)
COVID-19 网络网络扩展预测儿童严重疾病的临床和转化方法(CONNECT 预测患病儿童)
- 批准号:
10733696 - 财政年份:2021
- 资助金额:
$ 20.05万 - 项目类别: